drugset / Trial / NCT02537210

Aminosalicylic Acid Withdrawal Study in Long Standing Inactive Ulcerative Colitis

NCT02537210

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine whether aminosalicylic acid (ASA) can be safely withdrawn in patients with long-standing clinical inactive UC.

Timeline

Start
2015-09
Primary completion
2021-09-10
Completion
2021-09-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Mesalamine Small molecule 2 g Oral

Indications